Advanced search
Publication Cover
Postgraduate Medicine Volume 129, 2017 - Issue 8
Submit an article Journal homepage
280
Views
3
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Safety and effectiveness assessment of 2011–2012 seasonal influenza vaccine produced in China: a randomized trial

Gao Jing-XiaThe fifth Department of Biological products, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, People’s Republic of ChinaView further author information
,
Zhao Yu-LiangThe Vaccine Clinical Evaluation Center Department, Hebei Province Center for Disease Prevention and Control, Hebei, People’s Republic of ChinaView further author information
,
Liu Jin-FengDingxing County Center for Disease Prevention and Control, Dingxing County, Hebei Province, ChinaView further author information
,
Liu Shu-ZhenNational Institutes for Food and Drug Control, Beijing, ChinaView further author information
,
Liao Guo-YangThe fifth Department of Biological products, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Li QiThe Vaccine Clinical Evaluation Center Department, Hebei Province Center for Disease Prevention and Control, Hebei, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 907-914 | Received 24 May 2017, Accepted 15 Aug 2017, Published online: 05 Sep 2017

References

  • Guo Fang, Tao Rui, Shen Yunsong, et al. Study of the method of isolated and identified influenza virus. Int J Lab Med. 2010;31(4):409–411.
  • Shen Yan-Hua WZ. The RBC result analysis of severe influenza a adult patients’ death. Int J Lab Med. 2010;32(9):998–999.
  • Xiang-Xing Z, Kang-Sheng. L. The pandemic history of influenza: review and revelation of the influenza pandemic in last century. Med Soc. 2010;23(11):4–6.
  • Hanquet G, Van Damme P, Brasseur D, et al. Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine. 2011;29(3):370–377.
  • Mendelman PM, Cordova J, Cho I. Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults. Vaccine. 2001;19(17–19):2221–2226.
  • Treanor JJ, Campbell JD, Zangwill KM, et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med. 2006;354(13):1343–1351.
  • Yang Z, Dong Z, Fu C. Seasonal influenza vaccine effectiveness among children aged 6 to 59 months in southern China. PLoS One. 2012;7(1):e30424.
  • Steinhauer DA. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology. 1999;258(1):1–20.
  • Kang-Sheng ZX-XL. The history of influenza: the review and revelation for influenza pandemic in 20 century. Med Soc. 2010;23:4–6.
  • Dai Zongxiang, Zhou Jian, Cai Wei, et al. Study of safety and immunogenicity of trivalent seasonal influenza inactivated vaccine (split virion) in mouse. Chin J Vaccine Immunization. 2012;18(6):508–554.
  • Dai Zongxiang, Wang Xiangyi, Wang Jun, et al. Study of safety and immunogenicity of split influenza vaccine for children dosage form in mouse. Int J Lab Med. 2012;33(15):1793–1797.
  • SFDA. Good clinical practice (GCP) (board order no. 3). Beijing: People 's Health Publishing House; 2003.
  • ICH Guidance for Industry: E2E Pharmacovigilance Planning. [cited 2017 Jan]. Available from: http://www.fda.gov/cber/gdlns/ichpvp.htm
  • Research, F.a.D.A.C.f.B.E.a. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. 2007. [cited 2017 Jan]. Available from: http://www.fda.gov/cber/guidelines.htm
  • Bian Guolin, Lin Yongxing, Huang Meilin, et al. Evaluation on the safety and immunogenicity of domestic split influenza virus vaccine after inoculation. Chin J Health Lab Technol. 2012;22:1961–1963.
  • Li Guohua, Huang Qingxiao, Wang Rui, et al. A study and evaluation on safety and immunogenicity of the domestic inactivated trivalent split virus influenza vaccine. Chin J Vaccines Immunization. 2010;16:404–407,437.
  • Wu Jinyan, Chai Wenqing, Chu Yan, et al. Safety and immumogenicity of influenza vaccine （split virion）in humans. Chin J Biologicals. 2015;28:1173–1176.
  • WHO. [cited 2017 Jan]. Available from: http://gamapserver.who.int/gareports/Default.aspx?ReportNo=7
  • Xiao Qiyou, Li Fangjun, Huang Minghua, et al. Immunogenicity of trivalent seasonal influenza vaccine（split virion）inactivated in elders and the cross-reactive immunity to Novel Influenza A（H1N1）Virus. Chin J Vaccines Immunization. 2011;17:139–142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.